US Secretary of State Marco Rubio widens exemption for US aid after freezeUS Secretary of State Marco Rubio announced exemptions in the freeze on foreign assistance, continuing funding for humanitarian items like ...
Cipla sees no major impact on biz from Donald Trump admin's decision to pause foreign aid: Umang VohraCipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump adminis...
A US shutdown on foreign aid is hitting from Africa to Asia to Ukraine. Here's howU.S.-funded aid programs globally face halts and layoffs as a significant freeze on foreign assistance and domestic federal grants by the T...
Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
Big setback for Ukraine, Africa: US freezes almost all foreign aid except for Israel, Egypt armsThe United States, led by Secretary of State Marco Rubio under President Donald Trump's new "America First" policy, has frozen nearly all f...
Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...
Strides Pharma arm gets USFDA tentative nod for generic HIV treatment drugStrides Pharma Global, a subsidiary of Strides Pharma Science, has received tentative approval from the US FDA for its generic Dolutegravir...
Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tabletsThe tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for ...
Lupin gets USFDA nod for HIV drug under PEPFARLupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US...
US watch list may hit affordable drug businessIndia remains on Priority Watch List, and continues to be singled out for what the USTR considers to be inadequate protection of intellectu...
Aurobindo Pharma gets USFDA nod for HIV infection tabletsThis NDA was reviewed under the President's Emergency Plan for AIDS Relief (PEPFAR), Aurobindo Pharma said.
- Aurobindo turns billion dollar pharmaceutical company
Aurobindo Pharma has joined the billion-dollar club of pharma fraternity as the co's consolidated revenues registered a growth of 22.5%.
- Strides Arcolab receives US FDA nod for HIV drug
Drug firm Strides Arcolab today said it has received tentative approval from US health regulator for fixed dose combination of Lamivudine a...
- Now, US won't source AIDS drugs from Ranbaxy
US government will not source drugs under its global AIDS drug supply programme from Ranbaxy plants in India. Top food myths| Successful bi...
- Ranbaxy drugs in US AIDS programme under scanner
The development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.
- Indian firms get lion's share in US anti-AIDS funding
Aurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...
- Aurobindo gets USFDA nod for anti-HIV drug
Aurobindo Pharma Ltd on Wednesday said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 10...